Summary
How CNCT maps according to Revere
| Sector Level | Count |
|---|---|
Industries
|
1 |
Sectors
|
2 |
Subsectors
|
3 |
Product/Service Groups
|
13 |
Specific product example for CNCT
| Product Hierarchy |
|---|
*Healthcare
|
Biopharmaceuticals
|
Dermatology
|
Acne
|
Vulgaris
|
Antibacterial Agents
|
Lincosamides
|
Company Highlights:
Market Cap.
|
601.095 |
Current Shares Outstnd.
|
34.5 |
| Contact Name | John Higgins |
| Contact Phone | (650)8432800 |
| City, State | Palo Alto, CA |
| Dividends Per Common Share | 0.00 |
| Dividend Yield | n/a |
SI %SHOUT
|
6.17 |
IH % Shares Outst.
|
97.80% |
| Number of Employees | 394 |
| Revenue Per Employee | 202,452.1 |
| Book Value Per Share | 2.26 |
| 5 Year CAGR in Revenues % | 34.03 |
| 5 Year CAGR in Earnings % | -8.17 |
Asset Turnover
|
0.05 |
| Fiscal Year End | 12/31/2006 |
| Next Reporting Period | Dec, 2006 |
Business Description:
Chart:
| Last Price | 17.41 |
| Price Chg. | 0.00 |
| Price Chg. % | 0.00% |
| Open Price | 17.46 |
| High Price | 17.50 |
| Low Price | 17.41 |
| 52w High Price | 17.43 |
| 52w Low Price | 7.16 |
| Volume | 1,662,576 |
| 30d Avg. Volume | 450,964 |
Competitors by Products
| Products Manufactured/Services Performed/Product Name(s) - Competitors (Tickers)/Product Name(s): |
|---|
*Healthcare
|
Biopharmaceuticals
|
Dermatology
|
Acne
|
Vulgaris
|
Antibacterial Agents
|
Lincosamides
Products:
Pfizer Inc. (PFE) Products:
sanofi-aventis (ADR) (SNY) Products:
SkyePharma PLC (ADR) (SKYE) Products:
|
Antibacterial Agents/Retinoids
Products:
Medicis Pharmaceutical Corporation (MRX) Products:
|
Hair Disorders
|
Alopecia (Hair Loss)
|
Vasodilatory Agents
Products:
Perrigo Company (PRGO) Products:
Pfizer Inc. (PFE) Products:
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:
|
Lesion/Scaling Disorders
|
Dermatitis
|
Atopic (Eczema)
|
Steroidal Anti-Inflammatory Drugs (SAID)
Products:
Medicis Pharmaceutical Corporation (MRX) Products:
Pfizer Inc. (PFE) Products:
sanofi-aventis (ADR) (SNY) Products:
The Dow Chemical Company (DOW) Products:
Watson Pharmaceuticals, Inc. (WPI) Products:
|
Seborrheic (Dandruff)
|
Antifungal Agents
|
Imidazoles
Products:
Altana AG (ADR) (AAA) Products:
Barrier Therapeutics, Inc. (BTRX) Products:
Johnson & Johnson (JNJ) Products:
Medicis Pharmaceutical Corporation (MRX) Products:
Perrigo Company (PRGO) Products:
QLT Inc. (USA) (QLTI) Products:
Taro Pharmaceutical Industries Ltd. (TAROF) Products:
|
Dermatoses
|
Steroidal Anti-Inflammatory Drugs (SAID)
Products:
Altana AG (ADR) (AAA) Products:
Bausch & Lomb Inc. (BOL) Products:
Bristol Myers Squibb Co. (BMY) Products:
CollaGenex Pharmaceutical, Inc (CGPI) Products:
Johnson & Johnson (JNJ) Products:
K-V Pharmaceutical Company (KV/A) Products:
Medicis Pharmaceutical Corporation (MRX) Products:
Perrigo Company (PRGO) Products:
Pfizer Inc. (PFE) Products:
QLT Inc. (USA) (QLTI) Products:
Salix Pharmaceuticals Ltd (SLXP) Products:
sanofi-aventis (ADR) (SNY) Products:
Schering-Plough Corporation (SGP) Products:
Schwarz Pharma, Inc. (SWTZY) Products:
Taro Pharmaceutical Industries Ltd. (TAROF) Products:
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:
Watson Pharmaceuticals, Inc. (WPI) Products:
|
Psoriasis
|
Retinoids/Vitamin A Analogs
Products:
Allergan, Inc. (AGN) Products:
The Procter & Gamble Company (PG) Products:
|
Steroidal Anti-Inflammatory Drugs (SAID)
Products:
Medicis Pharmaceutical Corporation (MRX) Products:
sanofi-aventis (ADR) (SNY) Products:
Taro Pharmaceutical Industries Ltd. (TAROF) Products:
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:
|
Research/Preclinical Stage Products
Products:
Amarillo Biosciences, Inc. (AMAR) Products:
Amgen, Inc. (AMGN) Products:
Anesiva Inc. (ANSV) Products:
Barrier Therapeutics, Inc. (BTRX) Products:
Bioenvision, Inc. (BIVN) Products:
CombinatoRx, Incorporated (CRXX) Products:
Curis, Inc. (CRIS) Products:
Hana Biosciences, Inc. (HNAB) Products:
ICOS Corporation (ICOS) Products:
Inovio Biomedical Corp. (INO) Products:
Ligand Pharmaceuticals Inc. (LGND) Products:
Millennium Pharmaceuticals, Inc. (MLNM) Products:
NitroMed, Inc. (NTMD) Products:
OrthoLogic Corporation (OLGC) Products:
QLT Inc. (USA) (QLTI) Products:
Senetek PLC (ADR) (SNTKY) Products:
Sirna Therapeutics, Inc. (RNAI) Products:
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:
Valeant Pharmaceuticals International (VRX) Products:
Vaso Active Pharmaceuticals, Inc. (VAPH) Products:
XOMA Limited (XOMA) Products:
ZymoGenetics, Inc. (ZGEN) Products:
|
Immunology
|
Autoimmune Disorders
|
Psoriasis
|
Retinoids/Vitamin A Analogs
Products:
Allergan, Inc. (AGN) Products:
The Procter & Gamble Company (PG) Products:
|
Research/Preclinical Stage Products
Products:
A.P. Pharma, Inc. (APPA) Products:
Achillion Pharmaceuticals, Inc. (ACHN) Products:
ADVENTRX Pharmaceuticals, Inc. (ANX) Products:
Albany Molecular Research, Inc. (AMRI) Products:
Alexion Pharmaceuticals, Inc. (ALXN) Products:
Alfacell Corporation (ACEL) Products:
Alnylam Pharmaceuticals, Inc. (ALNY) Products:
Amarillo Biosciences, Inc. (AMAR) Products:
Amgen, Inc. (AMGN) Products:
Anadys Pharmaceuticals, Inc. (ANDS) Products:
Anesiva Inc. (ANSV) Products:
Antigenics, Inc. (AGEN) Products:
Arena Pharmaceuticals, Inc. (ARNA) Products:
ArQule, Inc. (ARQL) Products:
Array BioPharma Inc. (ARRY) Products:
Aspreva Pharmaceuticals Corporation (ASPV) Products:
AstraZeneca plc (ADR) (AZN) Products:
AtheroGenics, Inc. (AGIX) Products:
AVANIR Pharmaceuticals (AVNR) Products:
Bayer AG (ADR) (BAY) Products:
BioDelivery Sciences International, Inc. (BDSI) Products:
Bioenvision, Inc. (BIVN) Products:
Biogen Idec Inc. (BIIB) Products:
Bristol Myers Squibb Co. (BMY) Products:
Callisto Pharmaceuticals, Inc. (KAL) Products:
Carrington Laboratories, Inc. (CARN) Products:
Celera Group, Applera Corp. (CRA) Products:
Celgene Corporation (CELG) Products:
Cellegy Pharmaceuticals, Inc. (CLGY) Products:
Chelsea Therapeutics International Ltd. (CHTP) Products:
CombinatoRx, Incorporated (CRXX) Products:
Compugen Ltd. (USA) (CGEN) Products:
Critical Therapeutics, Inc. (CRTX) Products:
CuraGen Corporation (CRGN) Products:
Cyclacel Pharmaceuticals Inc. (CYCC) Products:
Dendreon Corporation (DNDN) Products:
DOR BioPharma, Inc. (DORB) Products:
Dr. Reddy's Laboratories Limited (ADR) (RDY) Products:
Dynavax Technologies Corporation (DVAX) Products:
Elan Corporation, plc (ADR) (ELN) Products:
Eli Lilly & Co. (LLY) Products:
Encysive Pharmaceuticals, Inc. (ENCY) Products:
EntreMed, Inc. (ENMD) Products:
Enzo Biochem, Inc. (ENZ) Products:
EPIX Pharmaceuticals, Inc. (EPIX) Products:
Favrille, Inc. (FVRL) Products:
Flamel Technologies S.A. (ADR) (FLML) Products:
Forbes Medi-Tech Inc. (USA) (FMTI) Products:
Forest Laboratories, Inc. (FRX) Products:
Genaera Corporation (GENR) Products:
Genetic Technologies Limited (ADR) (GENE) Products:
Genzyme Corporation (GENZ) Products:
Geron Corporation (GERN) Products:
Gilead Sciences, Inc. (GILD) Products:
GTC Biotherapeutics, Inc. (GTCB) Products:
Halozyme Therapeutics, Inc. (HTI) Products:
Hemispherx BioPharma, Inc (HEB) Products:
Hemosol Corp. (USA) (HML:CA) Products:
Hollis-Eden Pharmaceuticals Inc. (HEPH) Products:
Icagen, Inc. (ICGN) Products:
ICOS Corporation (ICOS) Products:
Idenix Pharmaceuticals, Inc. (IDIX) Products:
Idera Pharmaceuticals, Inc. (IDP) Products:
IDM Pharma Inc. (IDMI) Products:
Incyte Corporation (INCY) Products:
Inovio Biomedical Corp. (INO) Products:
InterMune, Inc. (ITMN) Products:
Introgen Therapeutics, Inc (INGN) Products:
ISIS Pharmaceuticals, Inc. (ISIS) Products:
Johnson & Johnson (JNJ) Products:
La Jolla Pharmaceutical Company (LJPC) Products:
Lexicon Genetics Incorporated (LEXG) Products:
Ligand Pharmaceuticals Inc. (LGND) Products:
MannKind Corporation (MNKD) Products:
Maxygen, Inc. (MAXY) Products:
Medarex, Inc. (MEDX) Products:
MedImmune, Inc. (MEDI) Products:
MGi Pharma, Inc. (MOGN) Products:
Micromet Inc. (MITI) Products:
Millennium Pharmaceuticals, Inc. (MLNM) Products:
MultiCell Technologies, Inc. (MCET) Products:
Myriad Genetics, Inc. (MYGN) Products:
Nabi Biopharmaceuticals (NABI) Products:
Nastech Pharmaceutical (NSTK) Products:
Neurocrine Biosciences, Inc. (NBIX) Products:
Novartis AG (ADR) (NVS) Products:
Novavax, Inc. (NVAX) Products:
Novogen Limited (ADR) (NVGN) Products:
NUCRYST Pharmaceuticals Corp. (USA) (NCST) Products:
Opexa Therapeutics Inc. (OPXA) Products:
OXIS International, Inc. (OXIS) Products:
Panacos Pharmaceuticals, Inc. (PANC) Products:
PDL BioPharma Inc. (PDLI) Products:
Pharmacopeia Drug Discovery, Inc. (PCOP) Products:
Pharmacyclics, Inc. (PCYC) Products:
Pharmaxis Ltd. (ADR) (PXSL) Products:
Pharmos Corporation (PARS) Products:
POZEN Inc. (POZN) Products:
Praecis Pharmaceuticals (PRCS) Products:
Progen Industries Limited (USA) (PGLA) Products:
Progenics Pharmaceuticals, Inc. (PGNX) Products:
Renovis, Inc. (RNVS) Products:
Rigel Pharmaceuticals, Inc. (RIGL) Products:
Roche Holding Ltd. (ADR) (RHHBY) Products:
Samaritan Pharmaceuticals, Inc. (LIV) Products:
Sangamo Biosciences, Inc. (SGMO) Products:
sanofi-aventis (ADR) (SNY) Products:
SCOLR Pharma Inc. (DDD) Products:
Seattle Genetics, Inc. (SGEN) Products:
Senesco Technologies, Inc. (SNT) Products:
Serono S.A. (ADR) (SRA) Products:
StemCells, Inc. (STEM) Products:
Sunesis Pharmaceuticals, Inc. (SNSS) Products:
Tanox, Inc. (TNOX) Products:
Telik, Inc. (TELK) Products:
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:
The Quigley Corporation (QGLY) Products:
Trimeris, Inc. (TRMS) Products:
Vernalis plc (ADR) (VNLS) Products:
Vertex Pharmaceuticals Incorporated (VRTX) Products:
Vion Pharmaceuticals, Inc. (VION) Products:
XOMA Limited (XOMA) Products:
ZymoGenetics, Inc. (ZGEN) Products:
|
Outsourced Services
|
Drug Delivery Technology
|
Topical Delivery
|
Lipid Based
Products:
Novavax, Inc. (NVAX) Products:
SkyePharma PLC (ADR) (SKYE) Products:
|
Polymer Based
Products:
A.P. Pharma, Inc. (APPA) Products:
Arrowhead Research Corporation (ARWR) Products:
Cardinal Health, Inc. (CAH) Products:
Genzyme Corporation (GENZ) Products:
Insite Vision Inc. (ISV) Products:
Noven Pharmaceuticals, Inc. (NOVN) Products:
QLT Inc. (USA) (QLTI) Products:
SkyePharma PLC (ADR) (SKYE) Products:
|
Key Financials
| Period Length/End |
3 months ending 09/30/2006 |
3 months ending 06/30/2006 |
3 months ending 09/30/2005 |
12 months ending 12/31/2005 |
12 months ending 12/31/2004 |
12 months ending 12/31/2003 |
| Total Revenue | 19.7 | 43.8 | 50.9 | 176.4 | 143.2 | 75.2 |
Gross Margin %
|
91.53 | 91.7 | 91.79 | 90.76 | 91.19 | 93.28 |
Operating Income
|
-27.7 | -3.0 | 11.3 | 16.0 | 20.9 | -2.6 |
Operating Margin %
|
-140.49 | -6.86 | 22.14 | 9.07 | 14.58 | -3.46 |
| Tax Rate % | 0.99 | 15.94 | 4.11 | -61.25 | 7.57 | -37.47 |
| Income After Taxes | -27.4 | -1.8 | 11.0 | 26.1 | 17.9 | -4.2 |
| Net Income Margin % | -139.04 | -4.09 | 21.53 | 14.81 | 12.52 | -5.53 |
F.D. EPS - Incl. Xord. Items
|
-0.81 | -0.05 | 0.27 | 0.70 | 0.48 | -0.13 |
| Book Value Per Share | 2.26 | 2.99 | 3.37 | 2.98 | 3.49 | 1.44 |
Ratios
P/R Ratio (TTM)
|
4.12 |
P/E Ratio (TTM)
|
n/a |
| Price To Free Cash Flow (TTM) | 108.32 |
| Price To Book Value | 7.84 |
| Net Assets to Market Cap. % | 51.95% |
| Beta | 0.77 |
Days to Sell Inventory
|
516.98 |
Current Ratio
|
4.63 |
Quick Ratio
|
4.06 |
| Interest Coverage | n/a |
| Debt to Market Cap. % | 48.25% |
| Return on Equity % | -24.11 |
| Return on Assets % | -4.41 |
| Return on Invested Capital % | -5.41 |